| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/18/2004 | US20040053993 Compositions of tocol-soluble therapeutics |
| 03/18/2004 | US20040053947 Pyrrolo[2,3-D]pyrimidine compounds |
| 03/18/2004 | US20040053880 Nucleic acid compositions for stimulating immune responses |
| 03/18/2004 | US20040053878 Zipper protein kindase and uses thereof |
| 03/18/2004 | US20040053877 Comprises Sendai virus (SeV) vector; analyzed using LacZ reporter gene and insulin-like growth factor; for treatment of neuromusclar disorders |
| 03/18/2004 | US20040053875 Comprises double-stranded RNA; extracted from HeLa cells |
| 03/18/2004 | US20040053874 Polynucleotide that hybridize with and inhibit gene expression for amphipathic dimeric glycoproteins |
| 03/18/2004 | US20040053873 Electroporation methods for introducing bioactive agents into cells |
| 03/18/2004 | US20040053872 Administering polynucletides that inhibit interactions polymerases with tRNA, to humans for prophylaxis of aquired immune deficiency syndrome |
| 03/18/2004 | US20040053868 Administering polynucleotides, BCL genes or proteins, fusion proteins and/or carrier mixtures, as antiapoptotic agents |
| 03/18/2004 | US20040053867 Nucleotide sequences that code for transport proteins; modulation of excitatory amino acids or signal tranduction; detoxification |
| 03/18/2004 | US20040053864 Prophylaxis and diagnosis of bone disorders such as osteoporosis or paget's disease, by controlling signal transduction, biosynthesis or receptor binding of polypeptide hormones |
| 03/18/2004 | US20040053863 Sensitization of HER-2/neu overexpressing cancer cells to chemotherapy |
| 03/18/2004 | US20040053858 Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract |
| 03/18/2004 | US20040053852 Preventing desensitization of receptors |
| 03/18/2004 | US20040053851 Association of calpain inhibitors and reactive oxygen species trapping agents |
| 03/18/2004 | US20040053850 Treatment of demyelinating diseases |
| 03/18/2004 | US20040053849 Inhibitors of the E2F-1/cyclin interaction for cancer therapy |
| 03/18/2004 | US20040053847 Suitable for treatment of cancer and for treatment, particularly topical treatment, of infections caused by pathogenic organisms such as bacteria and fungi |
| 03/18/2004 | US20040053846 Use of substances with immunomodulating activity for the treatment of amyotrophic lateral sclerosis |
| 03/18/2004 | US20040053845 Modified peptides as therapeutic agents |
| 03/18/2004 | US20040053844 Peptide and osteogenetic accelerator |
| 03/18/2004 | US20040053841 Treating an inflammatory condition in an individual by administering an agent which inhibits the interaction between a Toll-like receptor 2 and a high mobility group B polypeptide |
| 03/18/2004 | US20040053840 Using reagents that regulate human cyclophilin-like protein and reagents which bind to human cyclophilin-like protein gene products in preventing, ameliorating, or correcting dysfunctions or diseases including cancer |
| 03/18/2004 | US20040053839 Modulating apoptosis in a cell by administration of an apoptosis-modulating effective amount of an agent which interferes with prion protein-bax interaction |
| 03/18/2004 | US20040053838 Measuring serum IGF-I and/or IGF-I binding protein levels after birth of patient to obtain IGF-I or IGF-I binding protein level and correlating said level with in utero baseline level based on gestational age matched mean levels |
| 03/18/2004 | US20040053837 Using the core domain protein of PDGF-C, a new member of the PDGF/VEGF family of growth factors, or a homodimer or heterodimer comprising the core domain |
| 03/18/2004 | US20040053835 Reagents which regulate and bind to human NMDA receptor gene products can play role in preventing, ameliorating, or correcting dysfunctions or diseases including asthma, genito-urinary system disorders |
| 03/18/2004 | US20040053834 Relates to nucleic acid and amino acid sequences of enzymes involved in glycoprotein and glycolipid metabolism and use of these in diagnosis, treatment, and prevention of carbohydrate metabolism, cell proliferative, genetic, transport disorders |
| 03/18/2004 | US20040053833 Relates to regulation of activity of NET (ERP/SAP-2) protein and to compounds which modify or regulate NET protein activity; methods of screening for agonists or antagonists of NET in order to identify new pro- or anti-angiogenic compounds |
| 03/18/2004 | US20040053829 Polypeptide having preferably antitumoral and/or immunomodulating cytokine properties, which can be activated by processing in vivo comprising a central region with specific biological activity |
| 03/18/2004 | US20040053828 Partial peptide mimetics and methods |
| 03/18/2004 | US20040053826 Uses of polypeptides |
| 03/18/2004 | US20040053824 Nucleic acid and amino acid sequences |
| 03/18/2004 | US20040053821 Inhibitors of RGS proteins |
| 03/18/2004 | US20040053820 Histone deacetylase inhibitor |
| 03/18/2004 | US20040053819 Normalizing blood glucose levels by maintaining chronic steady state plasma levels of 60-200 picomoles/liter; subcutaneous injection 1-2 times every 24 hours |
| 03/18/2004 | US20040053817 Proinsulin C-peptide is present in an absorbable matrix of polyglycolide-lactide copolymers; antidiabetic agents |
| 03/18/2004 | US20040053816 Adipocyte culture-cells from fat tissue, liver and kidney from the carp |
| 03/18/2004 | US20040053408 Comprises anticoagulant/thrombolytic agent for selective dissolution of fibrin clots |
| 03/18/2004 | US20040053397 Comprises sodium glucose transport proteins for treating diabetes and hyperlipidemia; drug screening |
| 03/18/2004 | US20040053393 Comprises genetically engineered bacteriophage polymerase for detection and treatment of microorganismal infections |
| 03/18/2004 | US20040053389 or Metastatic-tumor Excreted Phosphaturic-Element (MERE) which effects phosphate metabolism ; for diagnosing and treating X-linked rickets, urogenital, kidney and bone disorders |
| 03/18/2004 | US20040053370 Comprises chimeric glucagon-like peptides-1 (GLP-1) for treating obesity and non-insulin dependent diabetes mellitus |
| 03/18/2004 | US20040053369 Dipeptidyl peptidases |
| 03/18/2004 | US20040053368 Collagen-binding hybrid polypeptide |
| 03/18/2004 | US20040053367 Lipid-associated molecules |
| 03/18/2004 | US20040053366 Comprises nucleotide sequences coding leptin chimeric polypeptide for treatment and prevention of weight and cardiovascular disorders |
| 03/18/2004 | US20040053364 Genetically engineered immunoglobulin receptor for modulating humoral response in transplant patients |
| 03/18/2004 | US20040053357 Nucleic acid encoding kv10.1 a voltage-gated potassium channel from human brain |
| 03/18/2004 | US20040053348 Nucleic acids and corresponding proteins entitled 282P1G3 useful in treatment and detection of cancer |
| 03/18/2004 | US20040053347 Braf35 protein and brca2/braf35 complex and methods of use |
| 03/18/2004 | US20040053329 Endoglin-specific polypeptide, production and use thereof |
| 03/18/2004 | US20040053325 Diagnostic assay and method of treatment involving macrophage inhibitory cytokine -1 (mic-1) |
| 03/18/2004 | US20040053316 Contacting composition with an aziridine derivative inactivating agent; killed virus-containing vaccines |
| 03/18/2004 | US20040053313 Activity dependent neurotrophic factor III (ADNF III) |
| 03/18/2004 | US20040053307 Comprises dual specificity membrane fusion proteins for treatment of transplant, allergenic, autoimmune and immunosuppressive disorders |
| 03/18/2004 | US20040053303 Comprises ubiquitin ligase for controlling/modulating weight gain and loss |
| 03/18/2004 | US20040053297 Cytokine-like proteins |
| 03/18/2004 | US20040053293 Novel core 2 beta-1,6-N-acetylglycosaminyltransferase gene |
| 03/18/2004 | US20040053292 Comprises nucleotide sequences coding polypeptide containing signal peptide sequences for treatment and prevention of psoriasis, asthma, artheriosclerosis, infections, meningitis, pneumonia and multiple sclerosis |
| 03/18/2004 | US20040053281 Comprises enzymatic polypeptide associated with fatty acid metabolism for diagnosing, treating and preventing cancer, neurodegenerative, autoimmune/inflammatory, gastrointestinal and cardiovascular disorders |
| 03/18/2004 | US20040053278 Smad6 and uses thereof |
| 03/18/2004 | US20040053276 Comprises protein factors for diagnosis, prevention and treatment of cancers, infections, immunological, gastrointestinal, organ and endocrine disorders; animal models for disease |
| 03/18/2004 | US20040053262 Supressor gene |
| 03/18/2004 | US20040053259 Comprises methylated antisense oligonucleotide sequence for regulation of urokinase type plasminogen activator and treatment of cancer |
| 03/18/2004 | US20040053247 Markers for prostate cancer |
| 03/18/2004 | US20040053244 Regulation of human galanin receptor-like g protein coupled receptor |
| 03/18/2004 | US20040053231 Comprises nucleotide sequences coding cbp/p3000 interacting transativators with ed-rich tails (HCITED) diagnosis, prevention and treatment hypoxia, cardioovascular, inflammatory, cancer and stroke disorders |
| 03/18/2004 | US20040053228 Apoptosis inhibitory polypeptides, gene and polynucleotide encoding it and compositions containing the same |
| 03/18/2004 | US20040053217 Using conjugate agents comprise of photoreactive moiety to identify preferential micro and/or macromolecules in heterologous mixtures |
| 03/18/2004 | US20040053206 Using tissue preservation solution to decrease reperfusion injury of an organ during surgery and/or following removal of organ |
| 03/18/2004 | US20040052928 A peptide containing at least 5 amino acid residues and less than 15 amino acid residues; |
| 03/18/2004 | US20040052922 Nutritional and therapeutical preparations having antioxidant activity |
| 03/18/2004 | US20040052869 Orally ingestible preparation of mistletoe lectins and method |
| 03/18/2004 | US20040052862 Glucagon-like peptide-1 (GLP-1); immunotherapy; for treatment of obesity |
| 03/18/2004 | US20040052860 Bone health compositions derived from milk |
| 03/18/2004 | US20040052855 Pouring a dissolved biodegradable polymer and a drug in a low water soluble solvents, a surfactant and homogenizing, filtering, washing and freeze drying |
| 03/18/2004 | US20040052841 Pharmaceutical preparation with retarding active ingredient release, method for its production and its use |
| 03/18/2004 | US20040052838 Erythropoietin liposomal dispersion |
| 03/18/2004 | US20040052835 Matrix controlled transdermal system for stabile derivatives of ace inhibitors |
| 03/18/2004 | US20040052820 Peptide containing amino acids 638 to 673 of the HIV-1LAI gp41 protein, and fragments, analogs and homologs of DP178, inhibitory of human and nonhuman retroviral, especially HIV, transmission to uninfected cells |
| 03/18/2004 | US20040052813 Polypeptide fragments of hepatitis e virus, the vaccine composition comprising said fragments and the diagnostic kits and the diagnostic kits |
| 03/18/2004 | US20040052810 Fusion protein; antitumor agents, antidiabetic agents, wound healing agents, antiulcer agents |
| 03/18/2004 | US20040052796 Anticancer agents; antitumor agents; controlling gene expression; quantitative analysis |
| 03/18/2004 | US20040052795 Wound healing agents, antiscarring agents |
| 03/18/2004 | US20040052794 Isolation antibodies; anticancer agents, antitumor agents |
| 03/18/2004 | US20040052789 Novel proteins genes encoding them and method of using the same |
| 03/18/2004 | US20040052786 Erbb4 antagonists |
| 03/18/2004 | US20040052785 Synergistic mixtures; antitumor agents |
| 03/18/2004 | US20040052783 Humanized antibodies against CD3 |
| 03/18/2004 | US20040052781 Vaccine compositions comprising Streptococcus pneumoniae polypeptides having selected structural motifs |
| 03/18/2004 | US20040052778 Mixture of iodide, thiocyanates, periodic acid and peroxygenase; viricides; killing spores |
| 03/18/2004 | US20040052777 Therapy for vision defects; angiogenesis inhibition |
| 03/18/2004 | US20040052767 Method for cell adhesion and wound healing |
| 03/18/2004 | US20040052766 Alzheimer's disease vaccine; induction antibodies, antigens |
| 03/18/2004 | US20040052762 Stat3 agonists and antagonists and therapeutic uses thereof |
| 03/18/2004 | US20040052750 Topical applying; adjust collagen biosynthesis; mixture of phenytoin, valproic acid, cyclosporin, nifedipine, diltazem,verapamil hydrochloride and amoldipine |
| 03/18/2004 | US20040050784 Method for the manufacture of compositions containing low concentrations of salts |
| 03/18/2004 | US20040050782 Solvent extraction to separate impurities; countercurrent fluid flow |